Keywords: expo, study, reinforces, supremacy, claims, astrazeneca, nexium

EXPO study reinforces supremacy claims for AstraZeneca's Nexium among PPIs

Article | 11 October 2004

Print This

New data from the EXPO (Efficacy of Healing and Maintenance Treatment with Esomeprazole and Pantoprazole in Subjects with Reflux Esophagitis) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in